Stifel Maintains Buy on GH Research, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Paul Matteis has maintained a Buy rating on GH Research (NASDAQ:GHRS) but has reduced the price target from $25 to $18.
December 18, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel analyst Paul Matteis maintains a Buy rating on GH Research but lowers the price target from $25 to $18.
The reduction in price target by Stifel, despite maintaining a Buy rating, could lead to a negative perception among investors, potentially causing a short-term dip in GHRS's stock price. Investors often view a lower price target as a sign of reduced growth prospects or increased risk, even if the overall recommendation remains positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100